As people get older, the hyaluronic acid in the face will be gone, and the volume of the face will lose gradually, this is why wrinkles and folds will appear. However, supplement of hyaluronic acid by injecting hyaluronic acid dermal filler will cause pains. This is why dermal filler with lidocaine is important, lidocaine helps to numb the skin and make the injection more comfortable, it can help reduce pain and discomfort during the injection process.
Singderm Universal is a sterile, biodegradable, nonpyrogenic, viscoelastic, clear, colorless, homogenized gel implant. Mono-phasic Dermal Filler consists of modified hyaluronic acid (HA) produced by bacteria, formulated to a concentration of 24 mg/ml and 0.3% lidocaine in a physiologic buffer. Indicated for injection into the mid to deep dermis or subcutaneous for correction of mid or deep depressions of the skin, as well as for correcting age-related volume deficit.
Singderm® is presented in a graduated, pre-filled, disposable syringe. Each box contains one syringe, an instruction leaflet and a set of labels in order to ensure traceability. The contents of the Singderm® syringe are sterilized by moist heat. If presense, the needles are sterilized by radiation or ethylene oxide.
Singderm Universal is indicated for facial tissue augmentation by injection into areas in which restoration is required, including reconstructive treatment of volume loss as well as for facial morphological asymmetry.
Facial fillers for sale offer a non-surgical way to rejuvenate your appearance by smoothing wrinkles and adding volume to your face.
| Singderm® | |||
| Indication | Indicated for facial tissue augmentation by injection into areas in which restoration is required, including reconstructive treatment of volume loss as well as for facial morphological asymmetry. | ||
| Injection Layer | Mid to deep dermis or subcutaneous | ||
| Duration | Up to 12 months | ||
| HA Concentration | 24mg/mL | ||
| HA Raw Material | Non Animal, produced by Streptococcus species of bacteria | ||
| Lidocaine | 0.3% | ||
| Water affinity | ●●◌◌◌ | ||
| G' (Hardness) | ●●●◌◌ | ||
| Cohesivity | ●●●●◌ | ||
| Specification | 1 mL | 2 mL | 10 mL |
| Enclosed Needles | 2*27G | 2*26G | NA |
| Certificate | NMPA CE MHRA TFDA Anvisa | ||
| Used in | Over 30 Countries | ||

World-class HA Raw Material
High Purity: this non-animal hyaluronic acid is produced through bacterial fermentation to ensure high purity.
High Quality: sourced from internationally advanced biotechnology. Selected high-quality hyaluronic acid raw materials.
High Assurance: product quality strictly adheres to the high standards of EP or JP and has passed high-quality clinical

All products were tested by TA rheometer under the same conditions using the same methodologies, and then gain the bar graph.
Superior Extensibility

Compared with similar products, Singderm® has demonstrated outstanding data results.
Its high viscoelasticity offer the possibility of its potential excellent clinical performance.
High Concentration of Effective HA
| Company | Singclean® | Company M | Company M | Company B | Company G |
| Brand | Singderm® | Brand B | Brand B | Brand C | Brand M |
| HA Content(mg/ml) | 24 | 22.5 | 26 | 20 | 24 |
| Cross-linked HA | 21.6(90%) | 8.325(37%) | 17.55(67.5%) | 16.4(82%) | 19(79%) |
| non cross-linked HA | 2.4(10%) | 14.175(63%) | 8.45(32.5%) | 3.6(18%) | 5(21%) |
High Concentration of Cross-linked HA to achieve good lifting effect and last longer.
Source: NMPA public information
Safety Assurance
| Safety Test Report | ||
| Test Items | Standard | Results of Testing |
| Protein Content | ≤0.1% | Qualified(0.04%) |
| Crosslinking Agent Residue | ≤2.0μg/g | Not detected |
| Sterility | Should be sterile | Sterile |
| Heavy Metal | ≤5μg/g | Conformity |
| Bacterial endotoxin | <0.5EU/mL | Conformity |
| Hemolysis | No hemolysis ring | Conformity |
Source: Singderm® Modified Sodium Hyaluronate Gel for injection Test Report, Report Number: BGI2510001
Clinical Effectiveness Rate

•The efficacy rate is measured by wrinkle severity rating scale(WSRS) from baseline.
•This clinical trial being a self-controlled study was performed in 3 top hospitals, 100 subjects participated.
Notably, Singderm® effectiveness rate at 12 months of 92.7% surpasses the 83% effectiveness rate reported for a leading comparator (Product J) at the same time point, indicating superior long-term efficacy.
Source 1: Clinical trial report on the efficacy and safety evaluation of Singderm®
Source 2: Product J IFU
Smooth Injection Experience
From the prefilled syringe market leader - BD HylokTM prefilled syringe
Hylok syringes are ideal for hyaluronic acid products, offering better storage and quality assurance.
The Hylok syringe's inner wall is sprayed with silicone oil for a more uniform application, ensuring smooth and stable injection.
The Hylok syringe utilizes a new technology in the front connector, effectively reducing the risk of needle burst and leakage during iniection.

Superior Extensibility
Compared to biphasic fillers, monophasic fillers exhibit superior extensibility, fits seamlessly with the surrounding tissue, bring natural beauty.
You can find a variety of facial fillers for sale, including hyaluronic acid-based options, which are popular for their natural-looking results. For further information about our products and to locate a certified provider near you, please visit our official website or contact us today. Rediscover your radiance and experience the beauty of Singderm Universal.
High-standard Production Process
28,000 ㎡ state-of-the-art intelligent manufacturing base features fully automated production lines
Operating within Class 10,000 and Class 100 cleanrooms, the entire process adheres to international standards.
Utilize USA polymer cellulose dialysis membranes to efficiently remove residual cross-linking agents and impurities.
German Optima aseptic filling technology ensures absolute protection against contamination.
Sweden Getinge sterilizer, achieving a terminal Sterility Assurance Level (SAL) of 10⁻⁶.




A. To Attach Needle to Syringe
STEP 1: Remove tip cap
Hold the syringe and pull the tip cap off the syringe as shown in Figure A
STEP 2: Insert the needle
Hold the syringe body and firmly insert the hub of the needle. into the luer-lock end of the syringe.
STEP 3: Tighten the needle
Tighten the needle by turning it firmly in a clockwise direction (see Figure B) until it is seated in the proper position as shown in Figure C.
NOTE: Continue to tighten until the needle is seated in the proper position.
STEP 4: Remove the needle cap
Hold the syringe body in one hand and the needle cap in the other. Without twisting, pull in opposite directions to remove the needle cap as shown in Figure D.
B. Physician Instructions
1) This product is designed to be injected into the dermis or the mucous membrane of the lips by an authorized medical practitioner in accordance with local applicable regulations. As precision is essential to a successful treatment, the product must be used by medical practitioners who have undertaken specific training in injection techniques for filling.
2) Before starting treatment patients should be informed of the product's indications, contra-indications, incompatibilities and potential undesirable effects.
3) The area to be treated should be disinfected thoroughly prior to the injection.
4) Follow the above attaching needle to syringe steps, and depress the plunger rod until the product flows out of the needle.
5) After the first small amount of material has been injected into the patient, wait a full 3 seconds to allow the lidocaine to take effect before proceeding with the rest of the injection.
6) The injection technique may vary with regard to the angle and orientation of the bevel, the depth of injection, and the quantity administered. A linear threading technique, serial puncture injections, or a combination of the 2 have been used to achieve optimal results. Injecting the product too superficially may result in visible lumps and/or discoloration.
7) Inject Singderm Universal by applying even pressure on the plunger rod while slowly pulling the needle backward. The wrinkle should be lifted and eliminated by the end of the injection. It is important that the injection be stopped just before the needle is pulled out of the skin to prevent material from leaking out or ending up too superficially in the skin.
8) If the needle is blocked, do not increase the pressure on the plunger rod. Instead, stop the injection and replace the needle.
9) The amount injected will depend on the areas which are to be corrected. Correct to 100% of the desired volume effect. Do not overcorrect. The degree and duration of the correction depend on the character of the defect treated, the tissue stress at the implant site, the depth of the implant in the tissue, and the injection technique.
10) When injection is completed, the treated site should be gently massaged so that it conforms to the contour of the surrounding tissues.
11) With patients who have localized swelling, the degree of correction is sometimes difficult to judge at the time of treatment. In these cases, it is better to invite the patient to a touch-up session after 1 to 2 weeks.
12) Patients may have mild to moderate injection-site responses, which typically resolve in a few days. If the treated area is swollen immediately after the injection, an ice pack can be applied to the site for a short period.
13) After the initial treatment, an additional treatment (from 1 to 2 weeks later) may be necessary to achieve the desired level of correction. If the wrinkle needs further treatment, the same procedure should be repeated until a satisfactory result is obtained. The need for an additional treatment may vary from patient to patient and is dependent upon a variety of factors such as wrinkle severity, skin elasticity, and dermal thickness at the treatment site.
14) The physician should instruct the patient to promptly report to her/him any evidence of problems possibly associated with the use of Singderm®.
Shelf life is 2 years, Store at 2°C to 30°C, DO NOT FREEZE.
Fragile.
• Singderm® is packaged for single-patient use. Do not resterilize. Do not use if package is opened or damaged.
• Patients should be limited to 20 mL of Singderm® per 60 kg (130 lbs) body mass per year. The safety of injecting greater amounts has not been established.
• As with all transcutaneous procedures, dermal filler implantation carries a risk of infection. Standard precautions associated with injectable materials should be followed.
• Singderm® is to be used as supplied. Modification or use of the product outside the Directions for Use may adversely impact the sterility, homogeneity, and performance of the product and it can therefore no longer be assured.
• The safety for use during pregnancy, in breastfeeding females, or in patients under 18 years has not been established.
• The safety in patients with known susceptibility to keloid formation, hypertrophic scarring, and pigmentation disorders has not been studied.
• Singderm® should be used with caution in patients on immunosuppressive therapy.
• Patients who are using substances that can prolong bleeding (such as aspirin, nonsteroidal anti-inflammatory drugs, and warfarin) may, as with any injection, experience increased bruising or bleeding at injection sites.
• After use, treatment syringes and needles may be potential biohazards. Handle and dispose of these items in accordance with accepted medical practice and applicable local, state, and federal requirements.
• Singderm® injectable gel is a clear, colorless gel without particulates. In the event that the content of a syringe shows signs of separation and/or appears cloudy, do not use the syringe.
• If laser treatment, chemical peeling, or any other procedure based on active dermal response is considered after treatment with Singderm®, there is a possible risk of eliciting an inflammatory reaction at the indications site. An inflammatory reaction is also possible if the product is administered before the skin has healed completely after such a procedure.
• Failure to comply with the needle attachment instructions could result in needle disengagement and/or product leakage at the luer-lock and needle hub connection.
• If the needle is blocked, do not increase the pressure on the plunger rod but stop the injection and replace the needle.
• Athletes should be made aware that this product contains an active principle that may produce a positive result in anti-doping test.
• Medical practitioners must take into account the fact that this product contains lidocaine.
• The composition of this product is compatible with fields used for magnetic resonance imaging.

Singderm® has been honored with multiple prestigious awards, reinforcing its position as an industry leader in China. Notable recognitions include:
•HA Filler Innovative Brand
•Most Loved HA Filler Brand
•Brand Voice Excellence Award
•Influential Brand of the Year


Committed to promoting high-quality development of global medical aesthetics
With 23 years of expertise in medical aesthetics R&D and manufacturing, Singclean is now one of the leading forces in the industry.
50+: Obtained local registration in over 50 countries
80+: Sales channels cover 80+ countries and regions
10%: Over 10% of revenue is spent on R&D each year
330: Have more than 330 global OEM ODM OBL partners
World-Class Manufacturing
Equipped with Asia's largest automated HA gel production facility, Singclean innovations are engineered to rigorous international GMP standards for unmatched quality and consistency.
Successful Brand Portfolio
Trusted by practitioners worldwide, Singderm, Singfiller and SKformula represent over 5 million syringes of proven clinical performance and physician confidence.
Unveiling the Next Generation of Aesthetics
Expanding beyond HA, Singclean introduces a rich portfolio of advanced aesthetic solutions — including biostimulators (PLLA, CaHA hybrid filler), PDRN skinboosters, post-treatment care, and natural skincare — designed to meet every clinical need.
| Product | Specification | Model No. |
Singderm® Modified Sodium Hyaluronate Gel for Injection | 1 mL | DF-SD-24-1.0 |
| 2 mL | DF-SD-24-2.0 | |
| 10 mL | DF-SD-24-10 |
Q: What is Singderm® dermal filler?
A: Singderm® dermal filler is made of 24.0mg/ml concentration cross-linked and 0.3% lidocaine, the HA is from microbial fermentation. It supplies good facial injection effects and painless injection experience.
Q: What are the advantages of Singderm® dermal filler?
A: No animal ingredients, Long lasting results Biodegradable, Good facial injection effects and Painless injection experience.
Q: Are you trading company or manufacturer?
A: We produce our own brand products in our own factory.
Q: How long is your delivery time?
A: Your order can be shipped within one day after you made the payment.
DHL or EMS delivery time: 3-7 days from China to other countries around the world.
Q: Do you provide samples?
A: Our MOQ is 10pcs. For your first order, you can order samples for checking quality.
Call us on:
Email Us:
No. 125(E), 10th Street, Hangzhou Qiantang Area, Zhejiang, China